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PRACTICAL APPLICATIONS
How to Select Replacement Grafts for Various Periodontal
and Implant Indications
Yung-Ting Hsu* and Hom-Lay Wang*†
Focused Clinical Question: How are bone re-
placement grafts for various periodontal and implant in-
dications properly selected?
Summary: The purpose of this paper is to review
the properties of available bone replacement materials
and provide guidelines of how to choose certain graft
materials for different clinical indications (e.g., periodon-
tal defects, peri-implant defects, socket augmentation,
ridge augmentation, and sinus augmentation).
Conclusion: Full understanding of material proper-
ties and meticulous case selection may help to maximize
the benefit of bone replacement grafts in tooth- and
implant-related regeneration. Clin Adv Periodontics
2013;3:167-179.
Key Words: Alveolar ridge augmentation; bone substi-
tutes; guided tissue regeneration; peri-implantitis; sinus
augmentation therapy; socket graft.
Background
Alveolar bone, as a part of periodontium, plays a primary
role in the maintenance of both the natural dentition and
dental implants. Resulting from periodontal disease or
trauma, bony destruction leads not only to functional
concerns but also esthetic impairment. To regain lost bone
tissue, the use of bone replacement grafts has been
introduced and widely applied in periodontal and im-
plant therapy.
Early researchers, Dr. Gerald Bowers and Dr. Robert
Schallhorn, established the fecundated principles of osse-
ous grafting by conducting a series of research projects over
the past decades. In a landmark article published in 1977,
the advantages of osseous grafting procedures was sug-
gested, including reconstruction of lost periodontium, ces-
sation of disease progression, and improvements in both
function and esthetics.1 Indeed, the efficacy of osseous
grafting has been demonstrated in histologic assess-
ments,2-6 which become the rationale for the use of bone
substitutes in modern dentistry.
Bone replacementmaterials have been used in several sit-
uations, such as infrabony defects,7 furcation defects,8
ridge augmentation,9 socket preservation,10 peri-implant
defects,11 and sinus augmentation.12 To achieve desirable
outcomes and maximal effectiveness, the selection of osse-
ous grafting materials should be based on their unique fea-
tures, therapeutic objectives, and indications.1 This paper
aims to provide guidelines for clinicians to select osseous
grafts for periodontal or implant indications. In addition,
the characteristics of bone substitutes used are reviewed.
Properties of Bone Replacement Grafts
An ideal bone replacement material should possess certain
features. Biocompatibility and non-toxicity are prerequi-
site, as well as resistance to infection. In addition to reason-
able cost, the ideal bone grafting materials should be easy
to manipulate and readily obtainable. They should also
possess some properties of regenerative potential or sup-
portability, i.e., osteogenesis, osteoinduction, and osteo-
conduction.1,13-15 In other words, osteogenic grafts have
the potential to trigger bone formation by transplantation
of osteoblasts and precursor osteoblasts. Osteoinductive
grafts provide a stimulus for the differentiations of bone-
forming cells, whereas osteoconductive materials only
serve as a scaffold for the migration and ingrowth of bone
cells.13,16
Based on graft sources, bone replacement materials are
classified into four categories with their unique character-
istics. The properties of each bone graft category is summa-
rized in Table 1. Table 2 summarizes the characteristics of
commercially available bone replacement grafts.
Autografts
Autogenous bone replacement grafts, transplanted within
the same individual, are obtained from either extraoral or
intraoral sites. In general, autografts are considered as the
gold standard in most clinical situations because of the ca-
pacity of osteogenesis and no risk of disease transmission.
With various harvesting techniques, characteristics of au-
tografts may representminor differences with regard to do-
nor sites. For example, cancellous bone and marrow grafts
possess the greatest induction potential of osteogene-
sis.17,18 Compared to the osseous coagulum techniques,
the bone blend technique yields the mixture of cortical
and cancellous graft of a larger particle size with clinically
manageable and predictable properties. However, osse-
ous coagulum and bone blend techniques can only pro-
cure a limited amount of bone, whereas cancellous bone
and marrow grafts lead to additional surgical insult and
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TABLE 1 Properties, Advantages, and Disadvantages of Bone Replacement Grafts
Bone Replacement Graft Properties Advantages Disadvantages Indications





Capacity of osteogenesis Limited availability Class II furcation defect























Possible osteogenesis Possible disease transmission Class II furcation defect















No need for additional
surgical intervention
Possible disease transmission 2-wall or circumferential
peri-implant defects






Alloplasts (synthetic grafts) Osteoconduction No risk of disease
transmission
Slow resorption rate 2-wall or circumferential
peri-implant defects








? = not enough evidence.
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expense.1,19,20 Additionally, root resorption is a common
concern when fresh iliac grafts are used.21,22
Allografts
Because of limited availability of autogenous bone grafts, al-
lografts have been introduced as alternative bone replace-
ment grafts in extensive bony defects. Allografts are
harvested from different individuals of the same species,
and they possess osteoconductive and osteoinductive prop-
erties and eliminate the need for a second surgical site. The
main alternative is autografts, but the main concernwith al-
lografts is the possible antigenicity and potential for disease
transmission, although the frequency is rare.23,24 To prevent
disease transmission, fresh-frozen grafts are no longer
used.25 Instead, freeze-dried bone allografts (FDBAs) and
decalcified FDBAs (DFDBAs) arewidely available from tis-
sue banks. Despite harvesting from similar sources, minor
differences of properties are presented. Compared to
DFDBA, FDBA tends to be more slowly resorbed and thus
is better for space maintenance. DFDBA has the potential
for osteoinduction with more expression of bone morphoge-
netic protein.26-28 Therefore, DFDBA is indicated for peri-
odontal regeneration, whereas FDBA is more suitable for
augmentation procedures.29 In addition, allografts can be
classified as cortical, cancellous, and mixed based on the
location of the donor site. It is believed that cancellous
bone shows better bone incorporation and more rapid re-
vascularization compared to cortical bone.30,31 However,
TABLE 2 Characteristics of Commercially Available Bone Replacement Grafts
Characteristics Commercial Name(s)
Allografts
DFDBA DBX Putty Demineralized Bone Matrix,* Grafton DBM,† OsteoDemin,‡ Regenaformx
FDBA MinerOss,† NonDemin,‡ CurOss,‡ CancellOss,‡ enCore Mineralized Allograft,‖
Puros Cancellous,{ Puros Cortical Bone{
Mixture of DFDBA and FDBA DynaBlast,# enCore Combination Allograft‖
Xenograft
Bovine bone OsteoGraf/N,* Bio-Oss,** NuOss XC Sinus/Socket Forms,†† NuOss††
Alloplasts
Non-resorbable HA OsteoGraf/D*
Resorbable HA OsteoGraf/LD,* OsteoGen‡
TCP chronOS Granules and Preforms‡‡
Mixture of HA and b-TCP OSTEON II,xx 4Bone,‖‖ OSTEON (sinus, orthopedic)xx
Calcium sulfate BondBone,‖‖ CaSO4 Calcium Sulfate Hemihydrate,†† SynOss††
Calcium phosphosilicate NovaBone Dental Putty{{
Collagen-coated bone grafts
Type I collagen-coated bovine bone PepGen P-15/PepGen P-15 FLOW,* Bio-Oss Collagen,** NuOss Collagen††
Type I collagen-coated alloplasts OSTEON Collagenxx
Combination of growth factor and bone grafts
Recombinant platelet-derived growth factor-BB and b-TCP GEM-21**
* DENTSPLY International, York, PA.
† BioHorizons, Birmingham, AL.
‡ Exactech, Gainesville, FL.
x Impladent, Holliswood, NY.
‖ Osteogenics Biomedical, Lubbock, TX.
{ Zimmer Dental, Carlsbad, CA.
# ACE Surgical Supply, Brockton, MA.
** Dentium, Cypress, CA.
†† Keystone Dental, Burlington, MA.
‡‡ Synthes, West Chester, PA.
xx Osteohealth, Shirley, NY.
‖‖ MIS Implant Technologies, Shlomi, Israel.
{{ NovaBone, Jacksonville, FL.
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FIGURE 1 Disease-related indications: periodontitis. SRP ¼ scaling and root planing.
FIGURE 2 Disease-related indications: peri-implantitis.
FIGURE 3 Implant-related indications: socket augmentation.
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limited evidence is available to clarify the differences and
the primary indications for these allografts.
Xenografts and Alloplasts
Osteoconductive bone replacement grafts include xeno-
grafts and alloplasts. Serving as the scaffold of bone re-
generation, xenografts are obtained from species other
than human, such as bovine, porcine, and coral.15 Similar
to allografts, xenografts avoid additional surgical insult in
regenerative procedures, leading to less patient discom-
fort. Despite osteoconduction, osteoinductibility of xeno-
grafts has also been demonstrated in an animal study.32
Nevertheless, iatrogenic transmission of prion-related
diseases is the main concern with the use of bovine prod-
ucts, although the risk has declined as a result of appro-
priate preventive measures.33 Synthetic bone substitutes
are alternatives as an osteoconductive scaffold in regener-
ative procedures and have no risk of disease transmission
and no need of second surgical sites. The types of allo-
plasts used in periodontal and implant indications include
absorbable/non-resorbable hydroxyapatite (HA) prod-
ucts, b-tricalcium phosphate (b-TCP), polymethylmetha-
crylate and hydroxylethylmethacrylate calcium-layered
polymer, polyactic acid polymer, and bioglass materials.
Instead of formation of new attachment, it appears that
alloplasts act as non-irritating fillers that support peri-
odontal repair.29,34
Additional Options
Recently, a revolution in properties of materials has been gen-
erated with the use of tissue engineering, the combination of
different bone materials, and the changes in processing tech-
niques. To improve the regenerative outcomes, the use of
synthetic collagen or growth factors in conjunction with
osteoconductive materials has been proposed to promote
both bone formation and to speed wound healing.8,35-37
Moreover, the combination of mineralized and demineral-
ized allografts has been introduced in addition to a mixture
FIGURE 4 Implant-related indications: ridge augmentation. DBBM ¼ deproteinized bovine bone mineral; ePTFE ¼ expanded polytetrafluoroethylene; PTFE ¼
polytetrafluoroethylene.
FIGURE 5 Clinical scenario 1. Pretreatment view of mandibular second
molar. An infrabony defect was noted on the distal aspect of tooth #31.
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of cortical and cancellous allografts. At present, there is lim-
ited evidence supporting the superiority of any of these com-
binations compared to a conventional formula.
Todate, there is no ideal bone replacementgraft that is suit-
able for all regenerative procedures. Selection of bone grafts
shouldbebasedonpropertiesofmaterials, indications/clinical
scenarios, and the purpose of the grafting procedures.
Decision Process and Clinical Scenarios:
Bone Grafts for Periodontal and Implant
Indications
The main indications of bone grafting procedures can be di-
vided intobothperiodontal and peri-implant disease-related
sites and implant site development applications. They in-
clude regenerative procedures for destruction caused by
periodontal or peri-implantdiseases andboneaugmentation
procedures for implant site preparation. In addition to de-
fect morphology, selection of bone replacement grafts
should be based on their properties corresponding to indica-
tions. Decision trees regarding disease-related and implant-
related indications are proposed in Figures 1 through 4.
Disease-Related Indications
Periodontal defects (clinical scenario 1). Bone replace-
ment grafts have been widely used in conjunction with
membrane barrier technique in guided tissue regeneration
(GTR) procedures. Intrabony defects and Class II furca-
tion defects are the main indications for bone grafting.38
In addition to formation of new attachment, favorable re-
sults in terms of probing depth reduction and clinical at-
tachment gain have been reported with the use of all
types of bone grafts.8,39-48 The additional benefits of
GTR in combination with bone grafts and growth fac-
tor–releasing devices, such as peptide coating, platelet-
rich plasma, and enamel matrix derivative protein, have
been evaluated and remain controversial.48-53 Compared
to allografts, limited evidence is available to support the
superiority of the use of xenografts or alloplasts in the
treatment of periodontal defects.54-57 In addition to the
concerns of disease transmission with xenografts, there
are few human trials with large sample sizes demonstrat-
ing the efficacy of alloplasts on periodontal regeneration.
Therefore, autologous bone grafts and allografts are rec-
ommended because of the capacity of osteoconduction,
osteoinduction, and osteogenesis (Fig. 1).
In Figure 5, a periodontal defect is shown on the distal
aspect of the mandibular secondmolar. After debridement,
an intrabony defect was noticed and treated with a GTR
procedure using mineralized allograft (Fig. 6). Promising
results with complete bone fill were achieved 4 years after
treatment (Fig. 7).
Peri-implant defects. Regenerative procedures have
been evaluated in the treatment of peri-implantitis.58,59 Re-
garding defect morphology of peri-implant lesions, guided
bone regeneration (GBR) is indicated in 2-wall or 3-wall
intrabony defects and circumferential defects (Fig. 2).60,61
In human models, various bone replacement grafts have
been applied to manage peri-implant bone loss with posi-
tive outcomes. They include autologous,62-64 alloge-
neic,11,58 xenogenic,63,65-67 and synthetic59,65,68,69 bone
substitutes. In a recent systematic review, the results sug-
gested that complete bone fill was achieved in £10.4%
of GBR-treated peri-implant lesions, whereas 85.5% of
peri-implant defects showed bone gain.70 Because of the
heterogeneity of experimental design, to date, limited evi-
dence is available to make a conclusion to suggest any
specific types of bone replacementmaterials. Additional re-
search is expected to address the regenerative procedures
in peri-implant lesions.
Implant-Related Indications
Socket augmentation (clinical scenario 2). To prevent
ridge resorption after tooth extraction, socket augmenta-
tion is necessary for future implant site development. The
use of bone replacement grafts allows better space creation
and maintenance by preventing potential collapse of mem-
branes. Compared to non-grafted sites or collagen-grafted
sites, desirable results in grafted sites have been shown
in previous studies, including less dimensional changes,
FIGURE 6 Clinical scenario 1. After full-thickness flap reflection and debride-
ment, a 3-wall infrabony defect was seen on the distal aspect of tooth #31.
FIGURE 7 Clinical scenario 1. Postoperative radiograph taken 4 years after
GTR.
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greater mineralized component, and better organization of
bone structures.10,71-73
In socket augmentation, it has been suggested that the
use of bone replacement grafts should be selected based
on the remaining walls of extraction sockets.74 However,
autologous bone failed to prevent ridge resorption despite
its osteogenic properties. Indeed, 25% of reduction was
shown on the coronal portion of the ridge.75Histologically,
allografts were replaced by newly formed bone, whereas
the extraction sockets grafted with xenografts exhibited
a delayed healing pattern.75-79 Up to 61% of vital bone fill
was reported in an allograft group compared to only 26%
in a xenograft group,79 although xenografts may have ben-
efits in minimizing dimensional changes.72,75 In addition,
fibrous encapsulation surrounding the residual bone parti-
cles has been observedwhen xenografts and alloplastswere
used as the graftingmaterials,76,80,81 leading to reduction of
bone-to-implant contact after implant placement.
In short, any type of a resorbable osseous graft is recom-
mended for placement in a socket with intact and thick
walls. For 2-wall or 3-wall sockets, both allografts and xe-
nografts are effective for socket augmentation. In a socket
with one bony wall remaining, a bone block graft or GBR
with particulate grafts might be a better option (Fig. 3).
Figures 8 through 10 show a socket augmentation pro-
cedure using mineralized bone putty that was applied
immediately after extraction of a fractured maxillary pre-
molar. Six months later, a full-thickness flap in the same
region was reflected for implant placement. Minimal di-
mensional changes were visualized, which provided a good
foundation for implant placement and restoration.
Ridge augmentation (clinical scenario 3). With the
advent of implant dentistry, techniques, such as onlay bone
grafting (OBG), ridge split/expansion, or GBRwith partic-
ulate bone grafts,82 were proposed for horizontal bone
augmentation. Techniques used to gain vertical height
included onlay block grafting, distraction osteogenesis,
and GBR.
For OBG, allogenic9,83 and xenogenic 84 bone blocks as
well as chin or ramus autografts85,86 have been used for hor-
izontal ridge augmentation. Although there is no need for
donor site, greater graft resorption has been reported in the
patients treated with allograft blocks compared to autolo-
gous block grafts.87 With a 7% to 8% failure rate, compli-
cations associated with cancellous block allografts were
significantly greater in the mandible than in the maxilla.88
In addition, the efficacy of xenogenic block grafts was also
evaluated in recent years. A feasibility studywas conducted
by Schwarz et al.84 to compare equine- and bovine-derived
cancellous bone blocks in lateral ridge augmentation in
a dog model. Minimal bone formation and grafting inte-
gration was shown in bovine grafts, although no adverse
events were reported. Thus, it is suggested that block auto-
grafts can be effective in both jaws, whereas block allo-
grafts may be more predictable for the maxilla. Block
xenografts may be a feasible option, but the efficacy re-
mains unknown.
Ridge split in combination with different particulate graft
has shown promising results in most studies.89-91 However,
limited evidence is available, especially when compared to
other treatment modalities. Regarding GBR, several techniques
and different graft materials have been used with satisfac-
tory results.92 With non-resorbable barrier membranes plus
FIGURE 8 Clinical scenario 2. Preoperative view of a fractured maxillary
premolar that was recommended for extraction.
FIGURE 9 Clinical scenario 2. Extraction socket was augmented using
mineralized bone putty and collagen dressing.
FIGURE 10 Clinical scenario 2. Reentry at 6 months after socket
augmentation for implant placement.
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tenting screws, promising outcomes have been achieved
with the majority of bone replacement grafts.93-96 In an an-
imal study, Fiorellini et al.95 demonstrated that implant os-
seointegration can be successfully achieved after GBR using
expanded polytetrafluoroethylene membranes regardless of
the types of osseous grafts used. Using absorbable barrier
membranes, ridge augmentation can be applied along with
simultaneous implant placement (Fig. 11), which is known
as the sandwich bone augmentation
technique. A combination of various
bone grafts is preferred. They include
layers of cancellous and cortical allo-
grafts97,98 (Fig. 12) and the mixture of
autogenous grafts and deproteinized
bovine bone mineral.99,100 This combi-
nation of bone replacement grafts is ad-
vantageous because of the capacity of
space maintenance with low-turnover-
ratebonegraftsandthepropertyof osteo-
genesis/osteoinduction/osteoconduc-
tion of autografts/cancellous allografts.
Compared to baseline, marked bone
formation was noticed after treatment
(Fig. 13).
Vertical ridge augmentation is one
of the greatest challenges in implant
dentistry. Despite high long-term implant survival rate
(92.1% to 100%), varying implant success rates (76.3%
to 97.5%) and vertical bone gain (2 to 8 mm) were dis-
cussed in a systemic review.101 Complications were also
demonstrated in various studies.91,102,103 Although desired
results have been suggested with the application of various
types of bone grafts,104-107 the predictability remains un-
clear. A proposed decision tree is shown in Figure 4.
Sinus augmentation (clinical scenario 4). In the max-
illary posterior region, a common ridge deficiency preventing
success implant placement is insufficient ridge height. To
increase vertical dimension, sinus augmentation proce-
dures have been widely applied in modern implant therapy,
resulting in high implant survival rates and a low incidence
of complications.108 Although the potential of bone forma-
tion in sinus without the use of bone substitutes has been
proposed,109 the results remain controversial, and the stabil-
ity of the blood clot with sinus lifting is questionable.110-113
From previous studies, comparable clinical outcomes and a
similar histologic appearance have been
suggested regarding the efficacyofdiffer-
ent types of bone replacement mate-
rials12,114-116 as long as the membranes
were not exposed. To date, no associa-
tion has been found between the type
of grafts used in sinus augmentation
and surgical outcomes in terms of im-
plant survival rates and occurrence of
complications.117 Despite the ability of
osteogenesis of autografts, resorbable
bone grafts with slow resorption may
also be suitable in sinus augmentation
procedures for dimension maintenance.118
Therefore, all types of bone replacement
grafts are suitable in sinus augmentation
procedures. Indeed, sinus elevation
FIGURE 11 Clinical scenario 3. 11a Preoperative view showing ridge deficiency and fenestration on the
buccal aspect of the implant. 11b Radiograph taken at baseline. Ridge deficiency was noted on the buccal
aspect of the edentulous ridge. Yellow arrow indicates the ridge deformity noted on the buccal aspect of
the edentulous ridge.
FIGURE 13 Clinical scenario 3. 13a Reentry at 6 months postoperatively. Predominant bone formation
and complete bone coverage were observed at the buccal aspect of the implant. 13b Radiograph taken 6
months postoperatively. Predominant bone formation on the buccal aspect of the implant was seen.
Yellow arrow indicates predominant bone formation on the buccal aspect of the ridge after GBR.
FIGURE 12 Clinical scenario 3. GBR with sandwich technique. Ridge
augmentation was performed using cancellous allografts as the inner layer
and cortical allografts as the outer layer.
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using a layered approach with various types of bone grafts
may be effective in achieving promising outcomes.
In Figures 14 through 16, a case of implant placement
with simultaneous sinus lifting is reported. A layered ap-
proach was performed in a 65-year-old patient who had in-
sufficient ridge height on the right maxillary posterior
region.With a lateral window technique, autogenous grafts
were placed in the apical portion (z5-mm height). The
middle portion consisted of cortical and cancellous allografts,
whereas the coronal portion was filled with the combina-
tion of xenograft and allografts, which have a slower resorp-
tion rate. A collagenmembrane was applied to cover the bone
grafts on the outside of lateral window. Two years after sur-
gery, both clinical and radiographic examination displayed
consistent and favorable results (Fig. 16).
Conclusions
With the advent of technology, autologous bone grafts re-
main the best choice inmost situations but are no longer the
only option inmodern dentistry. Various bone replacement
grafts from other sources are available, and they display
different properties. With various available grafts and re-
generative techniques, full awareness of their features
and indications is the cornerstone of successful regenera-
tion. Using these guidelines, careful case and material
selection corresponding to different indications can be
beneficial to achieve predictable and consistent treatment
outcomes. n
FIGURE 14 Clinical scenario 4. 14a Preoperative radiograph. Residual
ridge height was insufficient for implant placement. 14b Sinus elevation
was performed in a 65-year-old patient.
FIGURE 15 Clinical scenario 4. Sinus elevation with a collagen membrane
and layered approach using autografts (at the bottom), a mixture of cortical
and cancellous allografts (in the middle portion), and a mixture of
xenografts and allografts (as the top layer). Implants were placed
simultaneously with sinus elevation.
FIGURE 16 Clinical scenario 4. 16a Reentry at 2 years postoperatively.
16b Postoperative radiograph taken 2 years after sinus elevation.
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48. Döri F, Kovács V, Arweiler NB, et al. Effect of platelet-rich plasma on
the healing of intrabony defects treated with an anorganic bovine bone
mineral: A pilot study. J Periodontol 2009;80:1599-1605.
49. Sallum EA, Pimentel SP, Saldanha JB, et al. Enamel matrix derivative
and guided tissue regeneration in the treatment of dehiscence-type
defects: A histomorphometric study in dogs. J Periodontol 2004;75:
1357-1363.
50. Döri F, Huszár T, Nikolidakis D, Arweiler NB, Gera I, Sculean A. Effect
of platelet-rich plasma on the healing of intrabony defects treated with
P R A C T I C A L A P P L I C A T I O N S
Hsu, Wang Clinical Advances in Periodontics, Vol. 3, No. 3, August 2013 177
an anorganic bovine bone mineral and expanded polytetrafluoro-
ethylene membranes. J Periodontol 2007;78:983-990.
51. Hanna R, Trejo PM, Weltman RL. Treatment of intrabony defects with
bovine-derived xenograft alone and in combination with platelet-rich
plasma: A randomized clinical trial. J Periodontol 2004;75:1668-1677.
52. Kaigler D, Avila G, Wisner-Lynch L, et al. Platelet-derived growth
factor applications in periodontal and peri-implant bone regeneration.
Expert Opin Biol Ther 2011;11:375-385.
53. Pietruska M, Pietruski J, Nagy K, Brecx M, Arweiler NB, Sculean A.
Four-year results following treatment of intrabony periodontal defects
with an enamel matrix derivative alone or combined with a biphasic
calcium phosphate. Clin Oral Investig 2012;16:1191-1197.
54. Brown GD, Mealey BL, Nummikoski PV, Bifano SL, Waldrop TC.
Hydroxyapatite cement implant for regeneration of periodontal osse-
ous defects in humans. J Periodontol 1998;69:146-157.
55. Kothiwale SV, Anuroopa P, Gajiwala AL. A clinical and radiological
evaluation of DFDBA with amniotic membrane versus bovine derived
xenograft with amniotic membrane in human periodontal grade II
furcation defects. Cell Tissue Bank 2009;10:317-326.
56. Harris RJ. A clinical evaluation of an allograft combined with a
bioabsorbable membrane versus an alloplast/allograft composite graft
combined with a bioabsorbable membrane. 100 consecutively treated
cases. J Periodontol 1998;69:536-546.
57. Hall EE, Meffert RM, Hermann JS, Mellonig JT, Cochran DL. Com-
parison of bioactive glass to demineralized freeze-dried bone allograft
in the treatment of intrabony defects around implants in the canine
mandible. J Periodontol 1999;70:526-535.
58. Mellonig JT, Triplett RG. Guided tissue regeneration and endosseous
dental implants. Int J Periodontics Restorative Dent 1993;13:108-119.
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